Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Other(1)

Detailed Status

Active, not recruiting3
Completed3
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (14.3%)
N/A6 (85.7%)

Trials by Status

active_not_recruiting338%
recruiting113%
completed338%
unknown113%

Recent Activity

4 active trials
Showing 5 of 8
active_not_recruitingnot_applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

NCT06611553
active_not_recruitingnot_applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

NCT06611540
active_not_recruitingnot_applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

NCT06498661
recruitingnot_applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

NCT07281430
completednot_applicable

Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features

NCT03959410
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06611553Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02)

Active Not Recruiting
NCT06611540Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)

Active Not Recruiting
NCT06498661Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

Active Not Recruiting
NCT07281430Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

Recruiting
NCT03959410Not Applicable

Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features

Completed
NCT05595252

Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022

Unknown
NCT04809727Not Applicable

Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy

Completed
NCT01485731Phase 1

Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

Completed

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8